Inflammatory changes in newly formed vessels of carrageenin-induced granulomas after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.
D000818:Animals; D001808:Blood Vessels / Q000187:drug effects* / Q000196:embryology; D001920:Bradykinin / Q000494:pharmacology*; D002244:Carbon; D006528:Carcinoma, Hepatocellular; D002351:Carrageenan; D003102:Colloids; D006099:Granuloma / Q000139:chemically induced*; D007249:Inflammation / Q000139:chemically induced*; D007275:Injections, Intravenous; D007610:Kallikreins / Q000494:pharmacology*; D008113:Liver Neoplasms; D008244:Lysophosphatidylcholines / Q000494:pharmacology*; D008297:Male; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*
D003102:Colloids; D008244:Lysophosphatidylcholines; D012701:Serotonin; D002244:Carbon; D002351:Carrageenan; D007610:Kallikreins; D001920:Bradykinin